These findings align with recent studies that demonstrate a role for SARM1 in exacerbating mitochondrial dysfunction in a model of Charcot-Marie-Tooth disease type 2 A (CMT2A) (Sato-Yamada et al., 2022), which emphasises the importance of further investigating the impact of SARM1 on mitochondrial function. This evidence concerns the gene SARM1 and Charcot-Marie-Tooth disease type 2A1.